GI Tolerance and Acceptability of a New Thickener

A Study to Evaluate the GI Tolerance and Acceptability of a New Thickener for Dysphagia Patients

NCT04104815•Abbott Nutrition

Summary

The current study is designed to evaluate the gastrointestinal tolerance and acceptability of a new thickener for dysphagia patients.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subject has voluntarily signed and dated an ICF approved by an IRB/IEC, and provided applicable privacy authorization prior to any participation in the study.
•Subject is diagnosed with dysphagia.
•Subject is under the care of a Speech and Language Therapist and is currently using a thickener.
•Subject currently has normal GI function.
•Subject is interested in participating in the study, willing to comply with the study protocol and product.
•Subject who is able to consent and is able to evaluate the product.

Exclusion Criteria

•Subject has a normal swallow.
•Subject at high risk of aspiration with oral fluids requiring nil by mouth and enteral tube feeding.
•Subject has impaired renal function.
•Subject has liver failure, decompensated chronic liver disease, active hepatitis B or C receiving treatment, or hepatic encephalopathy.
•Subject has severe dementia or unable to communicate or consent or delirium, eating disorder, history of significant neurological or psychiatric disorder affecting abilities to answer questions, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures.
•Participant is known to be allergic or intolerant to any ingredient found in the study product.
•Participation in another study that has not been approved as a concomitant study.
•Subject has a clinical condition that is contraindicated with this product such as hepatic and renal disease.
•Subject has a clinical condition which may interfere with gastrointestinal tolerance.
•Subject is pregnant.

Key Dates

Start Date

February 5, 2021

Primary Completion Date

February 5, 2021

Completion Date

February 5, 2021

Last Updated

March 17, 2021

Conditions

Gastro-intestinal Tolerance

Interventions

Experimental Thickener

OTHER

Formula Tolerance of Term Infants

NCT04915937

Gastro-Intestinal Tolerance

View study

COMPLETEDNA

Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition

NCT04259437

Gastro-Intestinal Tolerance

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 17, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions